Concepedia

Dilip Rajagopalan

DR

Statistics

Publications

12

Citations

1K

H-Index

12

Active since

2003

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

Dilip Rajagopalan is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and omics.

Top concepts

Publications per year

2003–2014

12

Publications

12

Relationships between pazopanib exposure and clinical safety and efficacy in patients with advanced renal cell carcinoma

A. Benjamin Suttle, Howard Ball, Mathiéu Molimard et al. · British Journal of Cancer · 2014 · 180 citations · Full text

A global pathway crosstalk network

Yong Li, Pankaj Agarwal, Dilip Rajagopalan · Bioinformatics · 2008 · 159 citations · Full text

Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes

Chun‐Fang Xu, Nan Bing, Howard Ball et al. · Journal of Clinical Oncology · 2011 · 148 citations · Full text

Plasma Cytokine and Angiogenic Factor Profiling Identifies Markers Associated with Tumor Shrinkage in Early-Stage Non–Small Cell Lung Cancer Patients Treated with Pazopanib

Petros Nikolinakos, Nasser K. Altorki, David Yankelevitz et al. · Cancer Research · 2010 · 113 citations · Full text

, , +17

A comparison of statistical methods for analysis ofhigh density oligonucleotide array data

Dilip Rajagopalan · Bioinformatics · 2003 · 112 citations · Full text

1–5 of 12